Slough, United Kingdom

Sean Mason

This inventor holds 2 USPTO granted patents. Top assignee: Ucbbiopharma Srl. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sean Mason. Retrieved from https://idiyas.com/inventor/sean-mason-bmkaknnz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sean Mason - Innovator in Antibody Research

Introduction

Sean Mason is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for various medical applications, showcasing his dedication to advancing scientific knowledge.

Latest Patents

Sean Mason holds a patent for "Antibodies Against KLK5." This innovation represents a critical step in understanding and potentially treating conditions related to the KLK5 protein. His patent portfolio includes 1 patent, reflecting his focused contributions to the field.

Career Highlights

Sean is currently employed at UCB Biopharma Srl, where he continues to push the boundaries of research and development. His role at the company allows him to collaborate with other experts in the field, enhancing the impact of his work.

Collaborations

Some of Sean's coworkers include Neesha Dedi and Peter Charles Elliott. Their collective expertise fosters a collaborative environment that drives innovation and research forward.

Conclusion

Sean Mason's work in antibody research exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…